Bumetanide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bumetanide Injection (injection) from Mullan Pharmaceutical Inc. with status Resolved. The shortage was first posted on Dec 13, 2017.
Shortage details
- Status
- Resolved
- Company
- Mullan Pharmaceutical Inc.
- Package NDC
- 83301-0081-2
- Dosage Form
- Injection
- Presentation
- Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)
- Initial Posting
- Dec 13, 2017